Upexi, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
May 15, 2023 at 05:12 pm EDT
Share
Upexi, Inc. reported earnings results for the third quarter and nine months ended March 31, 2023. For the third quarter, the company reported sales was USD 24.22 million compared to USD 4.43 million a year ago. Net loss was USD 1.64 million compared to USD 0.052667 million a year ago. Basic loss per share from continuing operations was USD 0.11 compared to USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.11 compared to USD 0.01 a year ago. Basic loss per share was USD 0.11. Diluted loss per share was USD 0.11.
For the nine months, sales was USD 62.86 million compared to USD 13.28 million a year ago. Net loss was USD 1.57 million compared to net income of USD 0.523877 million a year ago.
Upexi, Inc. is a multi-faceted brand owner with brands in the health, wellness, pet, beauty, and other growing markets. The Company focuses on direct-to-consumer and Amazon brands. The Company utilizes its in-house software-as-a-service (SaaS) programmatic advertising technology to help achieve a lower cost per acquisition and accumulate consumer data for increased cross-selling between its growing portfolio of brands. Its Branded Product segment is focused on the development, growth, and distribution of the branded products that the Company own. Its Recommerce segment is focused on the purchase and sale of new and used products through channels, such as Amazon and wholesale distributors. The Companyâs brands include VitaMedica, Tytan Tiles, and others. VitaMedica offers clinician-originated nutraceuticals and cosmeceuticals products. VitaMedicaâs sales model includes wholesale distribution through surgeons and med spas and direct to consumers through e-commerce and marketplaces.
UPEXI, INC. 
